GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ondine Biomedical Inc (OTCPK:OBIMF) » Definitions » Short Interest

OBIMF (Ondine Biomedical) Short Interest


View and export this data going back to 2023. Start your Free Trial

What is Ondine Biomedical Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Ondine Biomedical's Short Interest

For the Biotechnology subindustry, Ondine Biomedical's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ondine Biomedical's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ondine Biomedical's Short Interest distribution charts can be found below:

* The bar in red indicates where Ondine Biomedical's Short Interest falls into.


;
;

Ondine Biomedical Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ondine Biomedical Inc (OTCPK:OBIMF) » Definitions » Short Interest
Comparable Companies
LSE:SBTX LSE:FUM LSE:TRX LSE:SAR LSE:AREC LSE:OPTI LSE:POLB LSE:IMM LSE:SNG LSE:OBD VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
OBI:UK VF5:Germany
Address
1100 Melville Street, Suite 888, Vancouver, BC, CAN, V6E4A6
Website
https://www.ondinebio.com
Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportable operating segment that is antimicrobial photodynamic therapy (aPDT) products.